Steven J. Feigenberg

faculty photo

Steven J. Feigenberg, M.D.

Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
Department: Radiation Oncology

Contact information
Department of Radiation Oncology
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 662-3998
Education:
B.S. (Chemical Engineering with Chemistry Minor (Cum Laude))
Drexel University , 1991.
M.D.
Hahnemann University School of Medicine, 1997.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Kyle Kim BS ⁎, Michele M. Kim PhD ⁎, Giorgos Skoufos PhD † ‡, Eric S. Diffenderfer PhD *, Seyyedeh Azar Oliaei Motlagh PhD *, Michail Kokkorakis BS ⁎ §, Ilektra Koliaki BS ⁎ §, George Morcos BS *, Khayrullo Shoniyozov PhD *, Joanna Griffin MS ║, Artemis G. Hatzigeorgiou PhD † ‡ ¶, James M. Metz MD *, Alexander Lin MD *, Steven J. Feigenberg MD *, Keith A. Cengel MD, PhD *, Bonnie Ky MD #, Constantinos Koumenis PhD *, Ioannis I. Verginadis PhD *: FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease. International Journal of Radiation Oncology*Biology*Physics Volume 119, Issue 4, 15 July 2024, Pages 1234-1247 July 2024.

Iocolano M, Yegya-Raman N, Friedes C, Wang X, Kegelman T, Lee SH, Duan L, Li B, Levin WP, Cengel KA, Konski A, Langer CJ, Cohen RB, Sun L, Aggarwal C, Doucette A, Xiao Y, Kevin Teo BK, O'Reilly S, Zou W, Bradley JD, Simone CB 2nd, Feigenberg SJ. : Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era. Cancer June 2024.

Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; RadComp (Radiotherapy Comparative Effectiveness Consortium). : Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial. Int J Radiat Oncol Biol may 2024.

Nikhil Yegya-Raman MD *, Abigail T. Berman MD, MSCE *, Christine A. Ciunci MD †, Cole Friedes MD *, Eva Berlin MD *, Michelle Iocolano MD *, Xingmei Wang MS ‡, Ching Lai BA *, William P. Levin MD *, Keith A. Cengel MD, PhD *, Shannon E. O'Reilly PhD *, Roger B. Cohen MD †, Charu Aggarwal MD, MPH †, Melina E. Marmarelis MD, MSCE †, Aditi P. Singh MD †, Lova Sun MD, MSCE †, Jeffrey D. Bradley MD *, John P. Plastaras MD, PhD *, Charles B. Simone II MD § ║, Corey J. Langer MD †…Steven J. Feigenberg MD *: Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics May 2024.

Adam Barsouk 1 #, Cole Friedes 2 #, Michelle Iocolano 2, Abigail Doucette 2, Roger B. Cohen 1, Kyle W. Robinson 1, Christopher A. D'Avella 1, Melina E. Marmarelis 1, John A. Kosteva 1, Aditi P. Singh 1, Christine A. Ciunci 1, William P. Levin 2, Keith A. Cengel 2, Jeffrey D. Bradley 2, Steven J. Feigenberg 2, Lova Sun 1, Charu Aggarwal 1, Corey J. Langer 1, Nikhil Yegya-Raman 2: Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation. Clinical Lung Cancer May 2024.

Nikhil Yegya-Raman MD *, Cole Friedes MD *, Sang Ho Lee PhD *, Michelle Iocolano MD *, Lian Duan BS *, Xingmei Wang MS †, Bolin Li BS *, Charu Aggarwal MD, MPH ‡, Roger B. Cohen MD ‡, William Su MD *, Abigail Doucette MPH §, William P. Levin MD *, Keith A. Cengel MD, PhD *, David DiBardino MD ║, Boon-Keng Kevin Teo PhD *, Shannon E. O'Reilly PhD *, Lova Sun MD, MSCE ‡, Jeffrey D. Bradley MD *, Ying Xiao PhD *, Corey J. Langer MD ‡…Steven J. Feigenberg MD *: Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics April 2024.

Cole Friedes MD *, Michelle Iocolano MD *, Sang Ho Lee PhD †, Bolin Li BS †, Lian Duan BS †, William P. Levin MD *, Keith A. Cengel MD, PhD *, Lova L. Sun MD, MSCE ‡, Charu Aggarwal MD, MPH ‡, Melina E. Marmarelis MD, MSCE ‡, Abigail Doucette MPH ‡, Roger B. Cohen MD ‡, Ying Xiao PhD †, Corey J. Langer MD ‡, Jeffrey Bradley MD *, Steven J. Feigenberg MD *, Nikhil Yegya-Raman MD : Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors. International Journal of Radiation Oncology*Biology*Physics 118, April 2024.

Elizabeth M. Nichols MD a, Søren M. Bentzen PhD, DMSc a, Meghan Milburn MD b, Susan B. Kesmodel MD c, Emily Bellavance MD d, Stewart J. Becker PhD d, Yildirim Mutaf PhD e, Katherine Tkaczuk MD d, Paula Rosenblatt MD d, Steven J. Feigenberg MD f: A Prospective Trial of Single-Fraction Radiation to the Tumor Bed with a Novel Breast-Specific Stereotactic Radiation Therapy Device: The GammaPod. Advances in Radiation Oncology April 2024.

Andrei Alexandru Mircea MD ∗, Teodora Donisan MD †, Steven Feigenberg MD ‡, Michael G. Fradley MD §: What do national radiotherapy guidelines for patients with cardiac devices teach us? Heart Rhythm O2 March 2024.

Feigenberg SJ, Costabile F, Pierini S, Kostopoulos N, Perales-Linares R, Uribe-Herranz M, Ben-Josef E, Koumeis C, Facciabene A. : Harnessing radiation and microbiome modulation for enhanced antitumor immune response in early-stage NSCLC treatment. Cancer Research March 2024.

back to top
Last updated: 07/11/2024
The Trustees of the University of Pennsylvania